Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
Alex S. Bennett, Tarlise Townsend, Luther Elliott
International Journal of Drug Policy (2021) Vol. 101, pp. 103554-103554
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City
Maria R. Khan, Lee Ann Hoff, Luther Elliott, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 60
A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives
Tom May, Jo Dawes, Daisy Fancourt, et al.
International Journal of Drug Policy (2022) Vol. 106, pp. 103752-103752
Open Access | Times Cited: 25
Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil
Fernando de Sá Del Fiol, Cristiane de Cássia Bergamaschi, Luciane Cruz Lopes, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Centering equity through in-person data collection: short report
Izza Zaidi, Leonardo Dominguez Gomez, Ashly E. Jordan, et al.
Journal of Public Health (2025)
Closed Access
Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation
Lisa Frueh, Alexandra B. Collins, Roxxanne Newman, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID‐19 pandemic: An interrupted time‐series analysis in Massachusetts, USA
Xiao Zang, Alexander Y. Walley, Avik Chatterjee, et al.
Addiction (2023) Vol. 118, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 9
Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States
Kristin E. Schneider, Emily Martin, Sean T. Allen, et al.
International Journal of Drug Policy (2024) Vol. 126, pp. 104371-104371
Closed Access | Times Cited: 3
Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: A national Delphi study
Louise Durand, Eamon Keenan, Fiona Boland, et al.
International Journal of Drug Policy (2022) Vol. 106, pp. 103768-103768
Open Access | Times Cited: 14
The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study
Mercy Ude, Czarina N. Behrends, Shea Kelly, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Fine-grained classification of drug trafficking based on Instagram hashtags
Chuanbo Hu, Bin Liu, Yanfang Ye, et al.
Decision Support Systems (2022) Vol. 165, pp. 113896-113896
Open Access | Times Cited: 13
COVID‐19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems
Noa Krawczyk, Bianca Rivera, Cale Basaraba, et al.
Addiction (2022) Vol. 118, Iss. 5, pp. 857-869
Open Access | Times Cited: 12
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
Kaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Pathways to racial disparities in the effects of Good Samaritan Laws: A mixed methods pilot study
John R. Pamplin, Carla King, Claire Cooper, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 110823-110823
Closed Access | Times Cited: 5
Exploration of weekly variation in naloxone possession and carriage among people who use opioids in New York City before, during, and after the COVID-19 pandemic
Alexis M. Roth, Kathleen Ward, Devon J. Hensel, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307151-e0307151
Open Access | Times Cited: 1
Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic
Allison Perry, Katherine Wheeler-Martin, Deborah S. Hasin, et al.
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111023-111023
Open Access | Times Cited: 2
Understanding Vaccine Perceptions and Willingness to Receive COVID-19 Vaccination: Opportunities to Strengthen Public Health Responses and COVID-19 Services for People Who Use Drugs
Ashly E. Jordan, Rwaida Izar, Renée Nicolas, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2044-2044
Open Access | Times Cited: 3
Application of Data Mining in Pharmaceutical Research
Zhenyu Pan, Limei Zhao, Deyong Jia, et al.
Frontiers research topics (2024)
Open Access
Determinants of psychological distress during the COVID‐19 pandemic among people who use drugs in Montreal, Canada
Iuliia Makarenko, Nanor Minoyan, Stine Bordier Høj, et al.
Drug and Alcohol Review (2024) Vol. 43, Iss. 7, pp. 2077-2088
Open Access
Bacterial Infections Risk Scale for Injection Drug Use: A Brief Screener to Identify Skin and Soft Tissue Infection Risk for People Who Inject Drugs
Leonardo Dominguez Gomez, Ashly E. Jordan, Izza Zaidi, et al.
(2024)
Closed Access
Historical and theoretical roots of the big events framework
Samuel R. Friedman, Diana Rossi, David C. Perlman
International Journal of Drug Policy (2024) Vol. 133, pp. 104606-104606
Closed Access
Disparities in Receipt of Medications for Opioid Use Disorder Before and During the COVID-19 Pandemic in the US Veterans Health Administration
Minhee Sung, Casey León, Joel I. Reisman, et al.
Substance Use & Addiction Journal (2024) Vol. 46, Iss. 2, pp. 369-376
Closed Access
Navigating the COVID-19 Risk Environment, Overdose Prevention, and Self Care Practices of People Who Use Illicit Opioids in New York City
Alex S. Bennett, David McCollum, Luther Elliott
Substance Use & Misuse (2024), pp. 1-11
Closed Access
Wound-associated agents in the unregulated drug supply: Evidence from a statewide drug checking program
Emily Martin, Kristin E. Schneider, Edward Sisco, et al.
International Journal of Drug Policy (2024) Vol. 135, pp. 104677-104677
Closed Access
Reducing opioid related deaths for individuals who are at high risk of death from overdose: a co-production study with people housed within prison and hostel accommodation during Covid-19
Anne Campbell, Sharon Millen, Li Guo, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 1
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
Kaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top